Verbod op levensmiddelen met ephedra-alkaloïden versneld

1. Haller CA, et al. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833-1838.
2. Shekelle PG, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003; 289: 1537-1545.
3. Lake OA, et al. Quality and safety of products containing Ephedra Herba on the Dutch market. Gewijzigde herdruk. RIVM Report 670220001/2001. Bilthoven: RIVM, 2001.
4. Anoniem. Ephedra-alkaloïden verboden in levensmiddelen. Persbericht, 6-2-2004. Den Haag, Ministerie van Volksgezondheid, Welzijn en Sport, 2004. [geraadpleegd op 29 mei 2004].
5. Marcus DM, et al. Ephedra-free is not danger-free. Science 2003; 301: 1669-1671.
6. Pellati F, et al. Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. J Pharm Biomed Anal 2002; 29: 1113-1119.
7. Calapai C, et al. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia 1999; 70: 586-592.